Yang Seung-rak
Director @ Kolon Investment
Yang Seung-rak is a Series A investor at Kolon Investment focused on Medical and Software. Yang Seung-rak
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Yang Seung-rak invests in
Stages Yang Seung-rak invests in
Countries Yang Seung-rak invests in
Investment Focus
Industry
- Medical 1 (50%)
- Software 1 (50%)
- Biopharma 1 (50%)
- Neuroscience 1 (50%)
- Biotechnology 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Autophagy Science is a company that focuses on the development of treatments for intractable diseases. Their work is based on a new mechanism known as autophagy. They are involved in drug discovery and have several therapeutic areas. These include NASH (AS-101), inflammatory bowel disease (AS-201), macular degeneration (AS-301), and degenerativebrain disease (AS-401). | $6.8M / Series A / Jan 19, 2021 | |
|
|
Neurophet is a medical technology enterprise that focuses on neuro-engineering and brain health. The company develops software programs that utilize artificial intelligence for the analysis of medical brain images. The firm creates simulation tools specifically for medical researchers and doctors who perform non-invasive electrical brainstimulation procedures. These applications allow medical professionals to generate three-dimensional models of individual human brains directly from magnetic resonance imaging data. | $4.5M / Series A / Dec 02, 2019 |
Co-Investors
About Kolon Investment
Kolon Investment, Inc. is a venture capital and private equity firm specializing in buyouts, mezzanine, corporate restructuring, growth capital, and turnaround investment. It prefers to invest in electronic components, petroleum, energy, computer, and telecommunications equipment. The firm primarily invests in South Korea with a focus in Seoul,Gyeonggi, Incheon, and Gyeongbuk. Kolon Investment, Inc. was established in 2000 and is based in Seoul, South Korea.Source: Businessweek
Kolon Investment Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Sang-Jun Ahn
CEO
|
|||
|
Yang Seung-rak
Director
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Yang Seung-rak invest in?
Yang Seung-rak invests primarily in Medical, Software and Biopharma startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Yang Seung-rak last invest?
The most recent investment recorded for Yang Seung-rak closed in Jan 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!